The above studies suggested that in addition to obesity control, OXT and its analogs can work in the brain to independently improve systemic insulin sensitivity and insulin secretion and thereof counteract against diabetes. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.